IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Immix Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$8.22+0.24 (+3.01%)
Close on Oct 19, 2026
- Market cap
- $524.20M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$29.96MFY2025